Trials / Conditions / Refractory Large B-cell Lymphoma
Refractory Large B-cell Lymphoma
4 registered clinical trials studyying Refractory Large B-cell Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Outpatient Epcoritamab as 2L in NTE R/R DLBCL NCT06811272 | Massachusetts General Hospital | Phase 2 |
| Recruiting | Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients NCT07473167 | TICAROS Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients NCT04836507 | Curocell Inc. | Phase 1 / Phase 2 |
| Completed | Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Rituximab in Participants With Refractory L NCT04002401 | Kite, A Gilead Company | Phase 2 |